Yep, I mean the o/s and float of CYDY are growing at incredible levels.....RGMP will get 50% of the net sales of Leronlimab, and CYDY gets 50%.....the clean share structure of RGMP just looks way more appealing to me.
As you say, there will likely be an offering at some point, I dont think they are going to be able to raise the money they need through the usually OTC way...convertible debt.
So IMO, I would not be surprised at all, given the apparent massive investor interest in Leronlimab(considering CYDYs volume and market cap).....that we could even eventually see them find an investment bank to underwrite an offering of $40M or more and get them off the OTC and to the big boards....that seems certainly plausible to me IMO.
News 
Market Data 
Discover 
